Figure 7.
Human vitreous levels of eicosanoids in PDR subtypes treated with bevacizumab, VH (n = 11) vs. TRD (n = 8) eyes. Comparison of levels (pg/mL) of 20-HETE, 20-COOH-AA in VH vs. TRD.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.